2022-12-15 |
13D/A
|
SRZN / Surrozen, Inc.
|
|
6,692,999 |
0 |
|
|
|
2022-02-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
1,969,875 |
0 |
|
|
|
2022-02-14 |
13G/A
|
CLRB / Cellectar Biosciences, Inc.
|
|
4,703,435 |
0 |
|
|
|
2022-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
2,729,709 |
0 |
|
|
|
2022-02-14 |
13G/A
|
SIOX / Sio Gene Therapies Inc.
|
|
6,058,505 |
0 |
|
|
|
2022-02-14 |
13G/A
|
CASI / CASI Pharmaceuticals, Inc.
|
|
7,576,431 |
0 |
|
|
|
2022-02-14 |
13G/A
|
GMDA / Gamida Cell Ltd.
|
|
3,287,745 |
0 |
|
|
|
2022-02-14 |
13G/A
|
US3723091043 / GenMark Diagnostics, Inc
|
|
4,480,163 |
0 |
|
|
|
2022-02-14 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
1,558,290 |
1,558,290 |
|
|
|
2021-09-29 |
13D/A
|
SRZN / Surrozen, Inc.
|
|
5,382,500 |
6,692,999 |
|
|
|
2021-08-18 |
13D/A
|
SRZN / Surrozen, Inc.
|
|
|
5,382,500 |
|
|
|
2021-04-27 |
13D/A
|
SRZN / Surrozen, Inc.
|
|
6,058,505 |
1,434,000 |
|
|
|
2021-02-17 |
13G/A
|
LMNL / Liminal Biosciences Inc
|
|
6,058,505 |
0 |
|
|
|
2021-02-17 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
6,058,505 |
0 |
|
|
|
2021-02-17 |
13G/A
|
/ Oxford Immunotec Global PLC
|
|
6,058,505 |
0 |
|
|
|
2021-02-17 |
13G/A
|
KDMN / Kadmon Holdings Inc
|
|
6,834,770 |
7,349,621 |
|
|
|
2021-02-17 |
13G/A
|
KPTI / Karyopharm Therapeutics Inc.
|
|
6,058,505 |
0 |
|
|
|
2021-02-17 |
13G
|
CLRB / Cellectar Biosciences, Inc.
|
|
6,058,505 |
4,703,435 |
|
|
|
2021-02-17 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
6,058,505 |
2,373,924 |
|
|
|
2021-02-17 |
13G
|
GMDA / Gamida Cell Ltd.
|
|
6,058,505 |
3,287,745 |
|
|
|
2021-02-17 |
13G
|
US3723091043 / GenMark Diagnostics, Inc
|
|
6,058,505 |
4,480,163 |
|
|
|
2021-02-17 |
13G/A
|
AXGN / Axogen, Inc.
|
|
6,058,505 |
0 |
|
|
|
2021-02-17 |
13G
|
CASI / CASI Pharmaceuticals, Inc.
|
|
6,058,505 |
7,576,431 |
|
|
|
2021-02-17 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
6,058,505 |
1,969,875 |
|
|
|
2021-02-17 |
13G/A
|
ARQL / ArQule, Inc.
|
|
6,058,505 |
0 |
|
|
|
2021-02-17 |
13G/A
|
APTO / Aptose Biosciences Inc.
|
|
6,058,505 |
0 |
|
|
|
2021-02-17 |
13G
|
PTGX / Protagonist Therapeutics, Inc.
|
|
6,058,505 |
2,729,709 |
|
|
|
2021-02-17 |
13G/A
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
6,058,505 |
0 |
|
|
|
2021-02-17 |
13G/A
|
OMER / Omeros Corporation
|
|
6,058,505 |
0 |
|
|
|
2021-02-17 |
13G/A
|
CDNA / CareDx, Inc
|
|
6,058,505 |
0 |
|
|
|
2021-02-16 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
1,878,395 |
1,969,875 |
|
|
|
2021-02-16 |
13G/A
|
/ Oxford Immunotec Global PLC
|
|
2,363,724 |
0 |
|
|
|
2021-02-16 |
13G
|
SIOX / Sio Gene Therapies Inc.
|
|
|
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
APTO / Aptose Biosciences Inc.
|
|
4,772,190 |
0 |
|
|
|
2021-02-16 |
13G
|
SIOX / Sio Gene Therapies Inc.
|
|
|
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
2,314,421 |
0 |
|
|
|
2021-02-16 |
13G/A
|
/ Oxford Immunotec Global PLC
|
|
2,363,724 |
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
APTO / Aptose Biosciences Inc.
|
|
4,772,190 |
6,058,505 |
|
|
|
2021-02-16 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
1,878,395 |
6,058,505 |
|
|
|
2021-02-16 |
13G
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
2,888,888 |
6,058,505 |
|
|
|
2021-02-16 |
13G
|
SRZN / Surrozen, Inc.
|
|
1,434,000 |
6,058,505 |
|
|
|
2021-02-16 |
13G
|
GMDA / Gamida Cell Ltd.
|
|
|
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
3,426,365 |
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
KDMN / Kadmon Holdings Inc
|
|
15,642,064 |
6,834,770 |
|
|
|
2021-02-16 |
13G/A
|
KPTI / Karyopharm Therapeutics Inc.
|
|
6,127,434 |
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
LMNL / Liminal Biosciences Inc
|
|
3,287,311 |
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
OMER / Omeros Corporation
|
|
3,195,796 |
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
ARQL / ArQule, Inc.
|
|
6,738,206 |
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
6,625,671 |
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
AXGN / Axogen, Inc.
|
|
2,986,386 |
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
CDNA / CareDx, Inc
|
|
2,121,976 |
6,058,505 |
|
|
|
2021-02-16 |
13G
|
CASI / CASI Pharmaceuticals, Inc.
|
|
|
6,058,505 |
|
|
|
2021-02-16 |
13G
|
US3723091043 / GenMark Diagnostics, Inc
|
|
|
6,058,505 |
|
|
|
2021-02-16 |
13G
|
CLRB / Cellectar Biosciences, Inc.
|
|
|
6,058,505 |
|
|
|
2021-02-16 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
5,166,961 |
1,558,290 |
|
|
|
2020-12-03 |
13D
|
SRZN / Surrozen, Inc.
|
|
|
1,434,000 |
|
|
|
2020-11-05 |
13G/A
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
2,240,779 |
1,252,229 |
|
|
|
2020-06-16 |
13G
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
2,240,779 |
|
|
|
2020-02-14 |
13G/A
|
KPTI / Karyopharm Therapeutics Inc.
|
|
4,810,078 |
6,127,434 |
|
|
|
2020-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
4,032,123 |
2,314,421 |
|
|
|
2020-02-14 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
4,658,759 |
0 |
|
|
|
2020-02-14 |
13G/A
|
SVRA / Savara Inc.
|
|
3,093,690 |
0 |
|
|
|
2020-02-14 |
13G/A
|
SESN / Sesen Bio Inc.
|
|
7,523,296 |
0 |
|
|
|
2020-02-14 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
6,211,964 |
0 |
|
|
|
2020-02-14 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
|
1,878,395 |
|
|
|
2020-02-14 |
13G
|
LMNL / Liminal Biosciences Inc
|
|
|
3,287,311 |
|
|
|
2020-02-14 |
13G
|
KDMN / Kadmon Holdings Inc
|
|
|
15,642,064 |
|
|
|
2020-02-14 |
13G/A
|
/ Oxford Immunotec Global PLC
|
|
2,579,784 |
2,363,724 |
|
|
|
2020-02-14 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
1,515,422 |
0 |
|
|
|
2020-02-14 |
13G
|
APTO / Aptose Biosciences Inc.
|
|
|
4,772,190 |
|
|
|
2020-02-14 |
13G/A
|
US55027E1029 / Luminex Corporation
|
|
2,402,787 |
0 |
|
|
|
2020-02-14 |
13G
|
OMER / Omeros Corporation
|
|
|
3,195,796 |
|
|
|
2020-02-14 |
13G
|
OVID / Ovid Therapeutics Inc.
|
|
|
2,888,888 |
|
|
|
2020-02-14 |
13G/A
|
QURE / uniQure N.V.
|
|
1,896,226 |
929,036 |
|
|
|
2020-02-14 |
13G/A
|
VCEL / Vericel Corporation
|
|
4,218,092 |
1,556,137 |
|
|
|
2020-02-14 |
13G
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
6,625,671 |
|
|
|
2020-02-14 |
13G
|
CDNA / CareDx, Inc
|
|
|
2,121,976 |
|
|
|
2020-02-14 |
13G
|
ISEE / IVERIC bio Inc
|
|
|
3,426,365 |
|
|
|
2020-02-14 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
4,588,352 |
5,166,961 |
|
|
|
2020-02-14 |
13G
|
ARQL / ArQule, Inc.
|
|
|
6,738,206 |
|
|
|
2020-02-14 |
13G
|
AXGN / Axogen, Inc.
|
|
|
2,986,386 |
|
|
|
2020-01-09 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
5,171,464 |
0 |
|
|
|
2019-12-09 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
13,260,963 |
5,171,464 |
|
|
|
2019-09-06 |
13D/A
|
PCRX / Pacira BioSciences, Inc.
|
|
2,340,089 |
2,075,970 |
|
|
|
2019-08-05 |
13D/A
|
PCRX / Pacira BioSciences, Inc.
|
|
2,789,916 |
2,340,089 |
|
|
|
2019-07-10 |
13D/A
|
PCRX / Pacira BioSciences, Inc.
|
|
3,205,559 |
2,789,916 |
|
|
|
2019-06-05 |
13D/A
|
PCRX / Pacira BioSciences, Inc.
|
|
3,652,134 |
3,205,559 |
|
|
|
2019-03-06 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
9,402,317 |
13,260,963 |
|
|
|
2019-02-14 |
13G
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
9,402,317 |
|
|
|
2019-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
3,644,438 |
4,032,123 |
|
|
|
2019-02-14 |
13G
|
/ Oxford Immunotec Global PLC
|
|
|
2,579,784 |
|
|
|
2019-02-14 |
13G
|
US55027E1029 / Luminex Corporation
|
|
|
2,402,787 |
|
|
|
2019-02-14 |
13G/A
|
VCEL / Vericel Corporation
|
|
3,381,303 |
4,218,092 |
|
|
|
2019-02-14 |
13G
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
4,810,078 |
|
|
|
2019-02-14 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
2,079,311 |
|
|
|
|
2019-02-14 |
13G/A
|
MDXG / MiMedx Group, Inc.
|
|
5,990,682 |
0 |
|
|
|
2019-02-14 |
13G/A
|
PACB / Pacific Biosciences of California, Inc.
|
|
7,065,920 |
2,455,114 |
|
|
|
2019-02-14 |
13G/A
|
RDUS / Radius Recycling, Inc.
|
|
2,649,285 |
|
|
|
|
2019-02-14 |
13G/A
|
SVRA / Savara Inc.
|
|
2,756,012 |
3,093,690 |
|
|
|
2019-02-14 |
13G
|
SESN / Sesen Bio Inc.
|
|
|
7,523,296 |
|
|
|
2019-02-14 |
13G/A
|
SPPI / Spectrum Pharmaceuticals, Inc.
|
|
7,383,466 |
2,969,027 |
|
|
|
2019-02-14 |
13G/A
|
STML / Stemline Therapeutics, Inc.
|
|
2,349,792 |
1,155,793 |
|
|
|
2019-02-14 |
13G
|
QURE / uniQure N.V.
|
|
|
1,896,226 |
|
|
|
2019-02-14 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
916,450 |
1,515,422 |
|
|
|
2019-02-14 |
13G
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
4,658,759 |
|
|
|
2019-02-14 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
3,367,635 |
4,588,352 |
|
|
|
2019-02-14 |
13G/A
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
24,476,520 |
9,450,763 |
|
|
|
2019-02-14 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
5,779,506 |
6,211,964 |
|
|
|
2018-10-22 |
13D
|
PCRX / Pacira BioSciences, Inc.
|
|
|
3,652,134 |
|
|
|
2018-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
2,772,156 |
3,644,438 |
|
|
|
2018-02-14 |
13G
|
RDUS / Radius Recycling, Inc.
|
|
|
2,649,285 |
|
|
|
2018-02-14 |
13G
|
MDXG / MiMedx Group, Inc.
|
|
|
5,990,682 |
|
|
|
2018-02-14 |
13G/A
|
PACB / Pacific Biosciences of California, Inc.
|
|
|
7,065,920 |
|
|
|
2018-02-14 |
13G/A
|
MACK / Merrimack Pharmaceuticals, Inc.
|
|
9,067,998 |
0 |
|
|
|
2018-02-14 |
13G
|
URGN / UroGen Pharma Ltd.
|
|
|
916,450 |
|
|
|
2018-02-14 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
1,273,933 |
3,367,635 |
|
|
|
2018-02-14 |
13G/A
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
25,052,380 |
24,476,520 |
|
|
|
2018-02-14 |
13G/A
|
ATRC / AtriCure, Inc.
|
|
2,666,354 |
0 |
|
|
|
2018-02-14 |
13G/A
|
CLVS / Clovis Oncology Inc
|
|
2,730,887 |
0 |
|
|
|
2018-02-14 |
13G
|
CORT / Corcept Therapeutics Incorporated
|
|
|
5,779,506 |
|
|
|
2018-02-14 |
13G
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
2,079,311 |
|
|
|
2018-02-14 |
13G
|
SVRA / Savara Inc.
|
|
|
2,756,012 |
|
|
|
2018-02-14 |
13G
|
SPPI / Spectrum Pharmaceuticals, Inc.
|
|
|
7,383,466 |
|
|
|
2018-02-14 |
13G
|
STML / Stemline Therapeutics, Inc.
|
|
|
2,349,792 |
|
|
|
2018-02-14 |
13G/A
|
VCEL / Vericel Corporation
|
|
2,982,940 |
3,381,303 |
|
|
|
2017-02-14 |
13G
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
25,052,380 |
|
|
|
2017-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
2,772,156 |
2,772,156 |
|
|
|
2017-02-14 |
13G/A
|
EGRX / Eagle Pharmaceuticals, Inc.
|
|
|
10 |
|
|
|
2017-02-14 |
13G
|
MACK / Merrimack Pharmaceuticals, Inc.
|
|
9,067,998 |
9,067,998 |
|
|
|
2017-02-13 |
13G/A
|
OFIX / Orthofix Medical Inc.
|
|
1,849,396 |
|
|
|
|
2017-02-13 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
3,460,323 |
2,772,156 |
|
|
|
2017-02-13 |
13G
|
MACK / Merrimack Pharmaceuticals, Inc.
|
|
|
9,067,998 |
|
|
|
2017-02-13 |
13G/A
|
EGRX / Eagle Pharmaceuticals, Inc.
|
|
1,406,137 |
|
|
|
|
2017-02-13 |
13G/A
|
OSIR / Osiris Therapeutics, Inc.
|
|
2,240,709 |
|
|
|
|
2017-02-13 |
13G/A
|
PACB / Pacific Biosciences of California, Inc.
|
|
5,498,712 |
|
|
|
|
2017-02-13 |
13G/A
|
VCEL / Vericel Corporation
|
|
2,352,940 |
2,982,940 |
|
|
|
2017-02-13 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
1,060,017 |
1,273,933 |
|
|
|
2017-02-13 |
13G/A
|
ANIP / ANI Pharmaceuticals, Inc.
|
|
946,489 |
491,608 |
|
|
|
2017-02-13 |
13G
|
ATRC / AtriCure, Inc.
|
|
|
2,666,354 |
|
|
|
2017-02-13 |
13G
|
CLVS / Clovis Oncology Inc
|
|
|
2,730,887 |
|
|
|
2016-02-11 |
13G/A
|
HPTX / Hyperion Therapeutics Inc
|
|
|
|
|
|
|
2016-02-11 |
13G
|
EGRX / Eagle Pharmaceuticals, Inc.
|
|
|
1,406,137 |
|
|
|
2016-02-11 |
13G/A
|
OFIX / Orthofix Medical Inc.
|
|
|
1,849,396 |
|
|
|
2016-02-11 |
13G/A
|
VCEL / Vericel Corporation
|
|
|
2,352,940 |
|
|
|
2016-02-11 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
|
937,516 |
|
|
|
2016-02-11 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
|
3,460,323 |
|
|
|
2016-02-11 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
|
1,060,017 |
|
|
|
2016-02-11 |
13G
|
OSIR / Osiris Therapeutics, Inc.
|
|
|
2,240,709 |
|
|
|
2016-02-11 |
13G
|
PACB / Pacific Biosciences of California, Inc.
|
|
|
5,498,712 |
|
|
|
2016-02-11 |
13G/A
|
CSII / Cardiovascular Systems Inc.
|
|
2,326,748 |
|
|
|
|
2016-02-11 |
13G/A
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
570,662 |
0 |
|
|
|
2016-02-11 |
13G/A
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
0 |
|
|
|
|
2016-02-11 |
13G/A
|
ANIP / ANI Pharmaceuticals, Inc.
|
|
|
946,489 |
|
|
|
2016-02-11 |
13G/A
|
PLX / Protalix BioTherapeutics, Inc.
|
|
0 |
|
|
|
|
2015-02-17 |
13G
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
|
3,427,789 |
|
|
|
2015-02-17 |
13G
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
1,696,147 |
|
|
|
2015-02-17 |
13G
|
VCEL / Vericel Corporation
|
|
|
2,352,940 |
|
|
|
2015-02-17 |
13G
|
TVTX / Travere Therapeutics, Inc.
|
|
|
2,551,535 |
|
|
|
2015-02-17 |
13G
|
ANIP / ANI Pharmaceuticals, Inc.
|
|
|
1,090,067 |
|
|
|
2015-02-17 |
13G/A
|
FURX / Furiex Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2015-02-17 |
13G
|
CSII / Cardiovascular Systems Inc.
|
|
|
2,135,200 |
|
|
|
2015-02-17 |
13G
|
ADMA / ADMA Biologics, Inc.
|
|
|
877,407 |
|
|
|
2015-02-17 |
13G
|
HPTX / Hyperion Therapeutics Inc
|
|
|
1,251,353 |
|
|
|
2015-02-17 |
13G
|
OFIX / Orthofix Medical Inc.
|
|
|
1,436,495 |
|
|
|
2015-02-17 |
13G
|
PLX / Protalix BioTherapeutics, Inc.
|
|
|
5,077,338 |
|
|
|
2015-02-17 |
13G
|
DSCI / Derma Sciences, Inc.
|
|
|
1,632,627 |
|
|
|
2015-02-17 |
13G/A
|
BIOS / BioPlus Acquisition Corp - Class A
|
|
|
1,177,145 |
|
|
|
2014-02-14 |
13G
|
FURX / Furiex Pharmaceuticals, Inc.
|
|
|
648,829 |
|
|
|
2014-02-14 |
13G
|
BIOS / BioPlus Acquisition Corp - Class A
|
|
|
3,921,333 |
|
|
|